Why physio sometimes stops being enough

Finishing a full course of physiotherapy and still living with knee pain is one of the more demoralising experiences in MSK medicine. Patients are often told to persist, to strengthen, to move more — and when that does not work, it can feel like a personal failure. It is not.

Physiotherapy is genuinely effective at what it targets: muscle imbalance, poor movement patterns, and the kind of pain sensitisation that amplifies discomfort well beyond the original injury. These are real contributors to knee pain, and addressing them is always worthwhile. The limitation is a structural one — exercise therapy cannot reverse cartilage thinning, repair a torn meniscus, dissolve bony osteophytes, or halt progressive narrowing of the joint space. When those changes are driving symptoms, physio reaches a ceiling.

The most common reason that ceiling is hit is knee osteoarthritis, a condition in which the cartilage lining the joint gradually wears down and the joint surfaces roughen. It affects more than 5 million people in the UK and is the fourth leading cause of disability worldwide — so if physio has not resolved things, you are far from alone.

What this situation calls for is not more of the same. It calls for a clearer picture of what is actually happening inside the joint — a structural diagnosis rather than another exercise programme.

Getting the right structural diagnosis

The step most people skip after failed physiotherapy is getting a precise structural diagnosis — and without one, treatment selection becomes guesswork.

A plain X-ray, which a GP typically orders first, shows bone density and the width of the joint space. What it cannot show is cartilage surface quality, early chondral damage, or the integrity of the menisci. Two patients with identical X-rays can have very different internal joint pictures. MRI is the primary tool for soft-tissue detail: it reveals cartilage thickness and signal change, meniscal tears, ligament integrity, and early bone marrow oedema. Where surgical planning is involved, CT adds a higher-resolution picture of bony anatomy that MRI alone does not provide.

When imaging is inconclusive — something is clearly wrong but the scans have not pinpointed it — dynamic needle arthroscopy allows direct, real-time visualisation of joint structures through a minimally invasive in-clinic procedure, without the resource demands of a formal arthroscopy under general anaesthesia.

There is also a functional layer that imaging does not capture. Objective biomechanical assessment can identify abnormal load-distribution patterns that sustain joint stress even when structural findings appear moderate. At MSK Doctors, that assessment layer includes AI-powered markerless motion capture through MAI Motion® — a UKCA-registered system that produces objective data on how the knee is actually being loaded during movement, complementing what scans show in isolation.

A specialist suitability assessment covering cartilage, meniscus, tendon, ligament, and injection pathways brings these layers together. That is the appropriate starting point before any escalated treatment is selected.

Injection options and what the evidence says

Once a structural diagnosis is in hand, intra-articular injections are usually the next step — and there are now four distinct options, each sitting at a different point on the spectrum from symptom control to tissue repair.

Corticosteroid injections are the most established. Delivered directly into the knee joint, they reduce inflammation rapidly and can bring meaningful pain relief within days. The evidence base for short-term symptom control is solid, which is why they remain widely used. The important caveat is that steroids are not regenerative — they address the inflammatory environment rather than the underlying structural change, and repeat courses over time may not sustain the same level of benefit.

Hyaluronic acid (viscosupplementation) takes a different approach, restoring lubrication to a joint whose own synovial fluid has thinned and lost its cushioning properties. Multiple Cochrane reviews and systematic meta-analyses support its use for symptom relief in early-to-moderate knee osteoarthritis, making it one of the better-evidenced options for patients at that disease stage.

Platelet-rich plasma (PRP) represents a step into regenerative territory. A small volume of the patient's own blood is centrifuged to concentrate its platelet-derived growth factors, which are then injected into the joint to reduce inflammation and encourage tissue repair. The overall evidence picture across musculoskeletal conditions is mixed — a 2020 review noted effectiveness varied significantly by condition — but the signal in knee osteoarthritis specifically is more consistently positive than in some other applications.

Polyacrylamide hydrogel (marketed as Arthrosamid) is the newest entrant. A 12-month open-label study in patients with advanced knee OA showed effectiveness and safety, with the gel acting as a sustained lubricant and volume-support medium within the joint. The evidence base is still maturing compared with older options.

Which injection is appropriate depends on the degree of cartilage loss, the pattern of symptoms, and individual suitability — factors a specialist assessment is designed to weigh. There is no single protocol that fits every knee.

Regenerative and cartilage-repair treatments

For patients in whom imaging confirms focal chondral damage rather than diffuse joint-wide degeneration, a dedicated tier of cartilage-preservation techniques becomes relevant — each matched to a different defect pattern and clinical profile.

NanoACi is a surgeon-led, one-stage procedure developed by Professor Paul Lee that delivers regenerative components to the repair site via needle rather than open or arthroscopic access, removing the arthroscope from the delivery pathway for suitable patients. That distinction carries real clinical weight: arthroscopic cartilage procedures involve general anaesthesia, surgical recovery, and procedural complexity that not every patient is well placed to accept. NanoACi aims to create a chondrogenic repair environment at the defect site; evidence for the technique's component elements exists, and combined-protocol outcomes continue to develop as clinical experience grows in appropriately selected candidates. It is a specialist procedure — needle delivery is the access route, not the whole intervention.

ChondroFiller is a collagen-scaffold injectable suited to focal cartilage defects with defined margins. The scaffold provides physical structure at the defect site — a framework within which repair tissue can organise — making it most relevant where surrounding cartilage is intact enough to support the repair environment.

Mytocel MSK contributes an autologous micrograft biologic component: material derived from the patient's own tissue that provides a cellular input to the regenerative process. It is typically used as part of a broader protocol rather than as a standalone option.

Suitability for any of these approaches depends on defect size and location, joint alignment, patient age and activity level, and imaging findings — not every patient will qualify. A structured specialist assessment that maps those variables is the appropriate entry point, not least because once joint replacement is carried out, these biological pathways are closed.

Joint-preserving surgery and knee replacement

Surgery enters the picture when injections and regenerative treatments have not provided sufficient relief, or when structural damage has progressed beyond their scope.

Osteotomy — either high tibial (HTO) or distal femoral (DFO) — corrects the mechanical alignment of the leg so that load is redirected away from the damaged compartment. It can delay the need for joint replacement by years, and suits younger, more active patients with compartmental osteoarthritis and appropriate bone geometry. Patient selection criteria are strict: the procedure is contraindicated in rheumatoid arthritis, significant joint instability, or fixed deformity beyond a defined degree, and the decision depends on careful imaging and biomechanical assessment rather than symptoms alone.

Arthroscopic techniques sit in the middle tier — relevant for specific structural problems such as meniscal pathology where the damage is focal and accessible, rather than diffuse across the whole joint.

Total knee replacement resurfaces the joint with metal and polyethylene implants, correcting alignment and eliminating bone-on-bone contact. For end-stage osteoarthritis that has not responded to non-surgical management, it is the definitive endpoint and frequently life-changing — but it is a major, permanent step, and the sequencing of earlier options matters accordingly.

Low-impact exercise (swimming, cycling, quadriceps strengthening) and weight management remain relevant throughout any surgical pathway, reducing mechanical load and supporting recovery.

What a specialist assessment actually involves

A useful post-physio assessment does several things simultaneously rather than in sequence. A clinician with a full diagnostic picture — structural imaging, joint examination, and a systematic review of injection and surgical pathways — can map realistic options in the right order, rather than sending a patient down one route and reconvening months later. That picture covers cartilage and meniscal status, which injection options are appropriate given the pattern and location of damage, and whether joint-preserving surgery is worth planning for — all considered together at a single appointment, not parcelled out across piecemeal GP referrals.

What distinguishes that kind of review from a standard referral is its scope: not one clinical question answered in isolation, but the whole diagnostic and suitability picture assembled before any treatment decision is made. For patients who have already exhausted conservative care, that joined-up approach tends to move things forward faster than navigating each pathway separately.

MSK Doctors clinics in Sleaford and Grantham carry out this assessment without a GP referral and without NHS-style waiting. Sleaford's on-site Open MRI supports same-site imaging for patients considering regenerative options; Grantham's MFO Life Sciences Lab extends that into research-informed practice. London-based patients can access the same consultant-led approach through the London Cartilage Clinic.

To book a specialist knee assessment without a referral, visit mskdoctors.com.

1. [1] Osteoarthritis. https://en.wikipedia.org/?curid=504841 https://en.wikipedia.org/?curid=504841
2. [2] Platelet-rich plasma. https://en.wikipedia.org/?curid=22050188 https://en.wikipedia.org/?curid=22050188